Clinical Trials Directory

Trials / Completed

CompletedNCT00861276

Nicotine Substitute Prescribed at Hourly Intake or ad Libitum for Heavy Smokers Willing to Quit

Use of Nicotine Substitute Prescribed at Hourly Intake or ad Libitum for Heavy Smokers Willing to Quit: a Randomized Controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
50 (actual)
Sponsor
University of Lausanne · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Objective: To assess the impact of instructional guidance in the regular use of use nicotine nasal spray (NNS) on the true use of NNS during the first three weeks of smoking cessation for heavy smokers who are willing to quit. Methods: This randomized, open, controlled trial included 50 patients who were heavy smokers, were willing to quit, and attending an academic outpatient clinic in Western Switzerland. Patients were randomised to instruction on NNS use as "ad libitum" (administration whenever cravings appear; control group) or to use NNS at least every hour when awake (intervention group). Intakes were monitored using an electronic device fixed in the spray unit (MDILogTM) during the first three weeks of use. Self reported abstinence from smoking at six months was confirmed by expired-air carbon monoxide. Using intention-to-treat analysis, random-effect GLS regression was used to calculate the mean difference of daily doses between groups controlling for lack of independence between measures from the same individual.

Conditions

Interventions

TypeNameDescription
DRUGNasal Spray Nicotine Substitute (Experimental)During the first month, subjects in the intervention group received instruction from the physician to use NNS regularly (at least 2 puffs/hour, for an average of 1 mg nicotine/hour when awake).
DRUGNasal Spray Nicotine Substitute (ad libitum)In the control group, participants were instructed to use NNS as needed to suppress withdrawal symptoms when cravings appeared.

Timeline

Start date
2000-06-01
Primary completion
2001-07-01
Completion
2001-12-01
First posted
2009-03-13
Last updated
2009-03-13

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT00861276. Inclusion in this directory is not an endorsement.